Citations

Clear

426 citation(s) found for "ST, Reza".

Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk Loci
Reddy, Joseph S. , Pereyra, Milagros , Abbas, Mohammed Tiseer , Arsanjani, Reza , Prah, Isaac E. , Boddicker, Nicholas , Cerhan, James R. , Larson, Melissa C. , Raphael, Mwangi, Habermann, Thomas M. , Villarraga, Hector R. , Luehrs, Anthony C. , Sicotte, Hugues , Egan, Jan B. , Moossavi, Maryam , Advani, Pooja , Ayoub, Chadi , Boddicker, Nicholas J , Vierkant, Robert A , Luehrs, Tony C , Sicotte, Hugues , Egan, Jan B , Lazaridis, Konstantinos N , Moossavi, Maryam , Lin, Xueying , Advani, Pooja P , Ayoub, Chadi , Norton, Nadine , Cerhan, James R , Habermann, Thomas , Arsanjani, Reza , Pereyra, Milagros , Abbas, Mohammed Tiseer , Larson, Melissa C , Prah, Isaac E. , Vierkant, Robert A. , Lazaridis, Konstantinos N. , Xu, Xiaolei , Norton, Nadine

Mayo Clinic

Circulation: Genomic and Precision Medicine | July 29, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/circgen.125.005651 | PMID 42522562 Get It

BACKGROUND: Anthracyclines are a widely used and effective class of chemotherapy. However, a major limitation for their use is cardiotoxicity, manifesting as systolic dysfunction, congestive heart failure, and arrhythmias. The objective of this study was to identify genes and genetic risk variants for doxorubicin-induced arrhythmia. METHODS: We performed genome-wide association studies and meta-analysis across 2 independent nonoverlapping, genetically homogenous data sets from the Molecular Epidemiology Resource (cases N=77, controls N=1184) and Tapestry (cases N=13, controls N=172). Doxorubicin-related arrhythmia was the primary cardiac outcome, followed by investigation of a broader phenotype of cardiac events. Effects of doxorubicin on top-associated genes were assessed by quantitative polymerase chain reaction on RNA extracted from human cardiomyocytes following treatment with doxorubicin and by echocardiography in a zebrafish model of doxorubicin-induced cardiomyopathy. RESULTS: In the meta-analysis, rs12151014 at the KCTD15 locus was associated with doxorubicin-related arrhythmia at the genome-wide significance (minor allele frequency in Molecular Epidemiology Resource cases 0.195 versus 0.069 in controls; Tapestry cases 0.192 versus 0.079 in controls) P =9.01×10 −9 ; odds ratio, 3.61. MMP 16 rs1094199 was associated with the broader phenotype of arrhythmia and heart failure (minor allele frequency in Molecular Epidemiology Resource cases 0.079 versus 0.019 in controls; Tapestry cases 0.038 versus 0.015) P =1.98×10 − 8 ; odds ratio=6.15. In human cardiomyocytes, MMP16 and KCTD15 gene expression was significantly downregulated by doxorubicin, and in a zebrafish MMP16 knockout was protective of doxorubicin-induced decline in left ventricular ejection fraction. CONCLUSIONS: Genetic variants at KCTD15 and MMP16 are associated with doxorubicin-related arrhythmia and cardiac events. MMP16 is a potential cardioprotective therapeutic target.
The Role of Multimodality Imaging in Guiding Ventricular Tachycardia Ablation: An Updated Review
Habib, Eiad, Abdelnabi, Mahmoud, Ibrahim, R, Kanaan, Christopher, Pham, Hoang Nhat, Alkhatib, Ahmad, Abdalla, Hesham, VanDolah, Hunter, Bacon, Adam, Tahsin, M T, Eldeib, Abdulrhman, Arsanjani, R A, Masry, Hicham El, Masry, Hicham El , Abdelnabi, Mahmoud , Jamal, Fares , El Masry, Hicham , Habib, Eiad , Kanaan, Christopher , Pham, Hoang Nhat , Alkhatib, Ahmad Muneer , Abdalla, Hesham, Tahsin, Malak , Arsanjani, Reza

Mayo Clinic

Reviews in Cardiovascular Medicine | July 27, 2026 | Volume: 27 | Issue: 5 | Pages: No page available

10.31083/rcm47045 | PMID 42238643 Get It

Multimodality imaging plays a pivotal role in ventricular tachycardia (VT) ablation by providing critical insights into arrhythmogenic substrates and guiding procedural strategies. This updated review explores the integration of various imaging techniques, including echocardiography, cardiac magnetic resonance (CMR), multidetector computed tomography (MDCT), electroanatomical mapping (EAM), and nuclear imaging, to optimize VT ablation outcomes. Echocardiography, particularly transthoracic echocardiography (TTE), is an essential first-line tool for evaluating structural heart disease and left ventricular function. Moreover, echocardiography aids in risk stratification and procedural planning by detecting regional wall motion abnormalities and thrombus formation. Meanwhile, intracardiac echocardiography (ICE) enhances ablation precision by providing real-time catheter visualization, improving procedural success, and reducing complications such as cardiac tamponade. Nonetheless, CMR is the gold standard for myocardial tissue characterization, enabling the identification of scar burden and conduction channels critical for VT pathogenesis. Late gadolinium enhancement (LGE) facilitates preprocedural planning by localizing arrhythmogenic substrates, predicting VT recurrence risk, and informing ablation strategies. Additionally, T1- and T2-mapping techniques refine the assessment of myocardial fibrosis and inflammation, further improving patient selection and outcomes. MDCT complements CMR by offering high-resolution anatomical visualization and aids in delineating scar distribution, epicardial fat, and vascular structures, informing safe and effective ablation approaches. The integration of these imaging modalities significantly enhances VT ablation precision, reduces recurrence rates, and improves patient outcomes.
Nutritional interventions in cardiac rehabilitation: current evidence, evidence gaps, and future directions—a scoping review
Elalfy, Aya, Abdelnabi, Mahmoud , Mohamed, Ahmed Elmorsy, VanDolah, Hunter , Sayed, Rana S., Kholeif, Zeyad, Rashwan, Rana , Ibrahim, Ramzi , Perone, Francesco , Arsanjani, R A, S Sayed, Rana , J Thomas, Randal, Ayoub, Chadi , VanDolah, Hunter , Perone, Francesco , Kholeif, Zeyad , Rashwan, Rana , Ibrahim, Ramzi , Thomas, Randal J. , Arsanjani, Reza

Mayo Clinic

European Journal of Preventive Cardiology | July 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/eurjpc/zwag375 | PMID 42480502 Get It

Abstract Aims Nutritional counselling is a core component of cardiac rehabilitation (CR), yet the evidence base for specific dietary interventions within CR remains fragmented. This scoping review aimed to map the range of nutritional interventions evaluated in adult CR programmes, characterize their reported outcomes, and identify key gaps in current evidence and practice. Methods and results Following the Arksey and O’Malley framework and reporting according to PRISMA-ScR, a systematic search of PubMed, Embase, Web of Science, and Cochrane Library was conducted from inception to June 2026. Eligible studies included randomized controlled trials, non-randomized trials, and observational studies evaluating an explicitly described nutritional intervention within a structured CR programme in adults with established cardiovascular disease. Of 2765 identified records, 35 studies met eligibility criteria. Interventions spanned Mediterranean and heart-healthy dietary patterns, calorie-restriction and weight-loss programmes, comprehensive lifestyle interventions, structured nutrition education and counselling, supplementation, functional foods, and individualized diet prescriptions. Across categories, improvements in body weight, central adiposity, and adherence to cardioprotective dietary recommendations were commonly reported, particularly when nutrition was delivered with repeated contact and individualized support. Effects on lipid profiles, inflammatory markers, blood pressure, functional capacity, and clinical outcomes were more variable. Conclusion Nutritional interventions within CR were most consistently associated with improvements in intermediate behavioural, anthropometric, and cardiometabolic outcomes, particularly when structured and reinforced over time. However, heterogeneity in study design, intervention delivery, comparator groups, outcome reporting, and follow-up duration precludes definitive conclusions about comparative efficacy, optimal intervention format, or the magnitude of benefit. Greater standardization, longer follow-up, and further evaluation of personalized nutritional strategies are needed to strengthen the nutritional component of CR.
Active Cerebrospinal Fluid Exchange Versus External Ventricular Drainage in IVH and SAH: A Meta-Analysis
Röblom, Albin, Niemelä, Mika, Salman, Saif , Tawk, Rabih G. , Jahromi, Babak S. , Freeman, William D. , Kashefiolasl, Sepide , Dashti, Reza , Jahromi, Behnam Rezai , Röblom, Albin , Salman, Saif D, Siddiqui, Adnan H , Tawk, Rabih G , Jahromi, Babak S , Freeman, William D , Kashefiolasl, Sepide , Dashti, Reza , Rezai Jahromi, Behnam , Bahadori, Amir Reza , Niemela, Mika R. , Siddiqui, Adnan H.

Mayo Clinic

Stroke: Vascular and Interventional Neurology | July 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/svin.125.002212 | PMID 42707794 Get It

BACKGROUND: Intraventricular hemorrhage and subarachnoid hemorrhage are associated with neuroinflammation and increased morbidity and mortality. Rapid clearance of blood from the cerebrospinal fluid space may mitigate neuroinflammatory cascades and improve clinical outcomes. This systematic review and meta-analysis aimed to compare the clinical effectiveness of active cerebrospinal fluid exchange, including neuroendoscopic lavage and IRRAflow systems, versus external ventricular drainage in patients with intraventricular hemorrhage or subarachnoid hemorrhage. METHODS: The study followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and thoroughly assessed databases, including PubMed, Embase, Scopus, Cochrane, and Web of Science, up to September 18, 2025. Statistical analysis, both fixed-effect and random-effect model analyses, was performed by the Comprehensive Meta-Analysis software. In addition, the Cochran Q test was conducted to determine the statistical heterogeneity. In terms of low heterogeneity, the fixed-effect model is reported. RESULTS: This review included 7 studies with a total sample size of 834. Our analysis showed that active cerebrospinal fluid exchange was associated with significantly higher hematoma clearance (odds ratio, 2.72 [95% CI, 1.22–6.08]; P =0.015), better functional outcomes (odds ratio, 1.66 [95% CI, 1.12–2.48]; P =0.012), lower shunt dependency (odds ratio, 0.22 [95% CI, 0.10–0.50]; P <0.001), and reduced infection rates (odds ratio, 0.22 [95% CI, 0.12–0.42]; P <0.001). Subgroup analysis showed that neuroendoscopic lavage was most effective for hematoma clearance, while IRRAflow reduced infection rates. Also, younger patients had better neurological recovery. CONCLUSIONS: Active cerebrospinal fluid exchange techniques demonstrated superior outcomes over external ventricular drainage in managing intraventricular hemorrhage and subarachnoid hemorrhage, particularly in clot resolution and neurological recovery. Large-scale trials are warranted.
Artificial intelligence-powered ECG is superior to NT-proBNP in predicting left ventricular systolic dysfunction in atrial fibrillation with rapid ventricular response
Baqal, O, Yee, C, Quillen, J, Mee, X C, Lim, G K, Ayoub, C, Arsanjani, R, Sorajja, D, Noseworthy, P A, Masry, H El, Baqal, Omar J , Mee, Xuan Ci , Arsanjani, Reza , Sorajja, Dan , Masry, Hicham El

Mayo Clinic

Europace | June 25, 2026 | Volume: 28 | Issue: Supplement_1 | Pages: No page available

10.1093/europace/euag105.1203 Get It

Abstract Introduction Despite its prevalence, risk stratification for tachycardia-induced cardiomyopathy remains poorly understood. A deep learning model developed at Mayo Clinic uses standard 12-lead electrocardiograms (ECGs) to predict reduced LVEF (≤35%) in the general population with high accuracy (AUC 0.93) Purpose We investigated the performance of AI-ECG in predicting systolic dysfunction among patients with atrial fibrillation and rapid ventricular response, and compared it with NT-proBNP. Methods We conducted a retrospective study (IRB approval #25-000904) of adult patients (age ≥ 18 years) evaluated across our Clinic enterprise with atrial fibrillation and rapid ventricular response (heart rate &gt;100 bpm), including AF occurring in-hospital and AF at presentation, between January 2017 and May 2025. We excluded patients with a known history of heart failure with reduced EF (&lt;50%). We also collected data on NT-proBNP levels when available within one week of the ECG and echocardiogram. Results A total of 11,801 patients were included, with a mean age of 73.2 +- 12.6 years, 48.6% female and 94.8% White. A combination of AI ECG low EF probability cutoff of 75% had specificity of 96% and 98% NPV in ruling out LVEF &lt; 35%. A combination of AI ECG low EF probability cutoff of 17% and LVEF &lt;35% provided the best balance of sensitivity and specificity, 66% and 78%, respectively with an accuracy of 78%. NT-proBNP data was available on 5,279 patients (48%). Mean NT-proBNP level was 4090 pg/mL. Based on ROC curve analysis, AI ECG was superior to NT-proBNP in predicting LVEF &lt;35% (AUC 0.72 vs 0.59), with accuracy of 77% versus 47% at Youden’s cutpoints of AI-ECG probability of 17% and NT-proBNP level of 1767 pg/mL, respectively Conclusions Our study demonstrates the utility of AI-ECG in predicting reduced LVEF among patients with AF RVR. AI-ECG demonstrated excellent specificity and NPV in ruling out reduced LVEF, serving as a powerful clinical screening tool to assist with the pharmacologic choice of rate control and could change the timing of further echocardiographic evaluation. Our study offers novel insights paving the way for future investigations to help fine-tune and further delineate the role of AI ECG in risk stratifying patients with suspected tachycardia-induced cardiomyopathy, guiding therapeutic and diagnostic clinical decisions
International Delphi consensus on single‐port robotic radical prostatectomy: patient selection, surgical technique, and training
Soputro, Nicolas , Bjurlin, Marc, Srivastava, Abhishek , Umbreit, Eric, Eltemamy, Mohamed , Pak, Raymond, Gelikman, David G. , Hopson, Nicholas, Geskin, Albert , Mehrazin, Reza, VanDyke, Maia, Nguyen, Carvell, Ornstein, David, Billah, Mubashir , Russell, Christopher, Yuh, Bertram, Thong, Alan, Olivares, Ruben, Shetty, Sugandh, Shakuri‐Rad, Jaschar , Baccala, Angelo, Osinski, Thomas, Simone, Giuseppe, Lee, D Y , Baker, Mark, Ramadan, Mohammad, Mattei, Agostino , Jafri, Mohammad, Galfano, Antonio, Link, Richard E. , Lam, Po, Jones, Marklyn, Bassett, Jeffrey C. , Musi, Gennaro, Schwen, Zeyad , Beksaç, Alp Tuna , Eden, C, Miller, Scott, Gontero, P, Amparore, Daniele, Porpiglia, Francesco, Vourganti, Srinivas , Ahmed, Mutahar, Montorsi, Francesco, Perdona, Sisto, Izzo, Alessandro, Stifelman, Michael D., Crivellaro, Simone, Briganti, Alberto, Kaouk, Jihad, Autorino, Riccardo, Soputro, Nicolas A , Eltemamy, Mohamed , Gelikman, David G , Geskin, Albert , Palese, Michael , Link, Richard E , Rais‐Bahrami, Soroush , Bjurlin, Marc A. , Umbreit, Eric , Mehrazin, Reza , VanDyke, Maia , Yuh, Bertram, Thong, Alan Eih Chih , Olivares, Ruben , Baccala, Angelo A., Osinski, Thomas L. , Simone, Giuseppe , Crouzet, Sébastien , Ramadan, Mohammad Said , Porreca, Angelo , Jafri, Syed M., Galfano, Antonio , Amparore, Daniele , Ahmed, Mutahar, Montorsi, Francesco , Perdonà, Sisto , Izzo, Alessandro , STIFELMAN, MICHAEL D. , Crivellaro, Simone, Briganti, Alberto , Kaouk, Jihad , Autorino, Riccardo

Mayo Clinic

BJU International | June 16, 2026 | Volume: 138 | Issue: 3 | Pages: 456-463

10.1111/bju.70346 | PMID 42297464 Get It

Introduction The introduction of the purpose‐built single‐port (SP) robotic platform has allowed for the advent of regionalized minimally invasive surgical approaches for robotic radical prostatectomy (RARP), including the extraperitoneal and transvesical techniques. This study sought to develop a best practice consensus on the key principles, patient selection, surgical techniques, expected clinical outcomes, and learning curves pertaining to SP‐RARP. Methods A modified Delphi consensus was developed by a panel of experts, consisting of a 33‐item questionnaire, with each statement rated using a binary Likert scale (‘agree’ or ‘disagree’). The survey was distributed via email to all practicing SP‐RARP surgeons across the USA and Europe. Consensus was defined as ≥75% agreement on a given statement. Results A total of 53 surgeons participated in the Delphi Consensus across the two rounds. Of 33 statements, 28 (84.8%) reached agreement in the first round. The remaining consensus was achieved in the second round, involving 35 surgeons, and with one additional statement. The panel agreed that, although are no absolute contraindications to SP‐RARP, the preference towards specific SP‐RARP techniques should remain guided by the individual patients and surgical expertise. Although the SP extraperitoneal technique is recommended to pursue pelvic lymph node dissections, the panel agreed that transvesical SP‐RARP showed promise in promoting shorter hospital stay, faster recovery of urinary continence, and utility in patients with extensive prior abdominal surgery. Consensus was also reached on the need for a structured training pathway, with most recommending beginning with extraperitoneal SP‐RARP before advancing to the transvesical approach. Conclusion This Delphi consensus demonstrates broad agreement among experienced SP surgeons in the USA and Europe, forming the foundation for future research on the clinical utility and necessary training pathways for SP‐RARP. Nevertheless, empirical validation based on clinical data from large cohort studies remains important.
NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026
Patel, Anand , Patel, Anand , Pollyea, Daniel Aaron , Altman, Jessica K. , Assi, Rita, Bachiashvili, Kimo, Bhatt, Vijaya Raj , Fathi, Amir T. , Fedorov, Kateryna, Foran, James M. , Gojo, Ivana , Goldberg, Aaron, Hall, Aric C. , Jonas, Brian A., Levine, Matthew R., Mangan, James, Mannis, Gabriel N. , Marcucci, Guido , Mims, Alice S , Moriarty, Kelsey, Ali, Moaath Mustafa, Neff, Jadee , Nejati, Reza , Olin, Rebecca L. , Patel, Anand, Percival, Mary‐Elizabeth M. , Perl, Alexander E. , Pettit, Kristen, Rao, Dinesh S. , Ravandi‐Kashani, Farhad, Schwabkey, Zaker, Shallis, Rory, Stahl, Maximilian, Stone, Richard M. , Thota, Swapna, Uy, Geoffrey L., Walker, Alison, Wang, Eunice, Awotiwon, Ajibola, Roth, Sydney L., Stehman, Katie

Mayo Clinic

Journal of the National Comprehensive Cancer Network | June 15, 2026 | Volume: 24 | Issue: 6 | Pages: 222-229

10.6004/jnccn.2026.0028 | PMID 42297017 Get It

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. It is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths from leukemias in the United States. 1 The NCCN Guidelines Panel for AML convenes annually to update recommendations for the diagnosis and treatment of AML in adults. These recommendations are based on a review of recently published clinical trials that have led to significant improvements in treatment or have yielded new information regarding biologic factors that may have prognostic importance. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding the monitoring and management of measurable (minimal) residual disease.
Artificial Intelligence-Driven Fractional Flow Reserve Assessment: Technical Foundations, Clinical Insights, and Future Directions
Hafez, Abdelrahman, Awad, Kamal, Farina, Juan M. , Nour, Mohamed , Reyad, Mohamed , Scalia, Isabel G. , Ahmed, Sherif, Abdelfattah, Fatmaelzahraa , Razaghi, Mahshad , Chollet, Laurève , Ibrahim, Ramzi, Tamarappoo, Balaji, Stib, Matthew, Ayoub, Chadi , Arsanjani, Reza , Mohamed, Mohamed Reyad , Villa Etchegoyen, Cecilia , Arsanjani, Reza , Farina, Juan M , Scalia, Isabel G , Hafez, Abdelrahman , Awad, Kamal , Ahmed, Sherif , Etchegoyen, Cecilia Villa , Ibrahim, Ramzi , Stib, Matthew T.

Mayo Clinic

Medicina | June 15, 2026 | Volume: 62 | Issue: 6 | Pages: 1157

10.3390/medicina62061157 | PMID 42356169 Get It

Coronary artery disease (CAD) remains a leading cause of global morbidity and mortality. Accurate diagnosis of ischemia-causing coronary stenoses is essential for guiding revascularization and improving outcomes. Although invasive fractional flow reserve (FFR) remains the gold standard for functional lesion assessment, its use is limited by procedural invasiveness, cost, and complexity. CT-derived FFR (FFRct), based on computational fluid dynamics (CFD), was the first major advance in noninvasive physiological assessment, but its adoption has been hindered by intensive off-site computation and dependence on high-quality imaging. This review summarizes the evolution from invasive FFR to AI-driven functional assessment of coronary lesions. We examine the principles and validation of CFD-based FFRct and then focus on the shift toward artificial intelligence, including both machine learning (ML) and deep learning (DL) approaches. These methods range from models using engineered geometric and plaque features trained on large synthetic datasets to end-to-end systems that learn directly from imaging data. We discuss key validation studies evaluating diagnostic accuracy, prognostic value, and clinical utility, with attention to performance in challenging settings such as intermediate stenoses, heavy calcification, and patients with comorbidities. We also highlight major barriers to widespread adoption, including dependence on input data quality, limited explainability, regulatory hurdles, and integration into clinical workflows. Finally, we outline future directions, including AI-enabled virtual PCI planning, multimodal risk stratification, and broader access to functional cardiac assessment. AI has the potential to transform noninvasive coronary imaging by enabling a single CCTA scan to provide rapid, integrated evaluation of anatomy, plaque characteristics, and physiological significance, supporting more personalized care and better clinical outcomes.
Exploring the landscape of artificial intelligence in dental and maxillofacial radiology: a bibliometric analysis of studies and trends
Anil, Gokhan , Mahapatro, Abinash , Alotaibi, Abdulhadi, Joukar, Farahnaz, Mansour-Ghanaei, Fariborz, Hassanipour, Soheil, Delbari, Reza, Hendi, A, Koochaki, Mahsa , Korsapati, Hariprasad Reddy , Koochaki, Mahsa , Amiri, Mohammad Amin , Alotaibi, Abdulhadi , Joukar, Farahnaz , Mansour‐Ghanaei, Fariborz , Hassanipour, Soheil , Keivanlou, Mohammad‐Hossein , Hendi, Amirreza

Mayo Clinic

Annals of Medicine & Surgery | June 2, 2026 | Volume: 88 | Issue: 7 | Pages: 4272-4287

10.1097/ms9.0000000000005013 | PMID 42433750 Get It

Background: The integration of artificial intelligence (AI) in dental and maxillofacial radiology is revolutionizing diagnostic accuracy and clinical decision-making. This bibliometric analysis investigates the research landscape, emerging trends, and scholarly impact of AI applications in this specialized field. Methods: A comprehensive search was conducted on 25 December 2024 using the Web of Science Core Collection database. Data analysis tools, including VOSviewer, CiteSpace, and Biblioshiny, were employed to examine publication trends, global contributions, collaborative networks, and keyword dynamics. Results: The analysis revealed a marked increase in AI-related publications in dental and maxillofacial radiology, particularly from 2016 onward. The number of studies rose steadily, reaching 218 publications in 2024. The United States led in research output, followed closely by China and South Korea, with KU Leuven emerging as the top-contributing institution. Reinhilde Jacobs was identified as the most prolific author, while Medical Physics was the most cited journal. Co-citation analysis highlighted influential works by authors such as J.H. Lee and F. Schwendicke . Keywords including “artificial intelligence,” “deep learning,” “CBCT,” and “classification” dominated research discussions, reflecting the field’s evolving focus. Recent research trends emphasize advanced applications in segmentation, accuracy enhancement, and predictive modeling. Conclusion: AI has become integral to the advancement of dental and maxillofacial radiology, offering significant improvements in diagnostic precision and treatment planning. This study underscores the importance of staying abreast of AI innovations to enhance patient care and foster future research opportunities. Researchers and clinicians are encouraged to adopt AI-driven approaches to maximize clinical efficiency and outcomes.
Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure
Ibrahim, Ramzi, Dreher, Luke, Habib, E., Pham, Hoang Nhat, Ibrahim, Sammudeen , Bhakta, Mayurkumar, Sorajja, Dan , Shen, Win-Kuang, Scott, Luis R., Ayoub, C A, Arsanjani, R A, Masry, Hicham Z. El, Masry, Hicham El , Nabi, Hussein Abdul , Farina, Juan María, Tan, Min Choon , Noureldine, Hussein A , El Masry, Hicham Z, El Masry, Hicham , Ibrahim, Ramzi , Dreher, Luke , Farina, Juan M. , Pham, Hoang Nhat , Bhakta, Mayurkumar D. , Lee, Kwan , Scott, Luis R. , Arsanjani, Reza

Mayo Clinic

JAMA Network Open | May 26, 2026 | Volume: 9 | Issue: 5 | Pages: e2614674

10.1001/jamanetworkopen.2026.14674 | PMID 42189543 Get It

This cross-sectional study investigates the association between lipoprotein(a) levels and risk of ventricular arrhythmias among patients with heart failure with reduced ejection fraction receiving implantable cardioverter-defibrillator therapy.